Aberdeen Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$75.9M Sell
296,552
-113,827
-28% -$29.1M 0.13% 149
2025
Q1
$90.6M Buy
410,379
+42,123
+11% +$9.3M 0.18% 113
2024
Q4
$84.4M Sell
368,256
-29,554
-7% -$6.78M 0.16% 138
2024
Q3
$96.3M Buy
397,810
+33,451
+9% +$8.1M 0.18% 133
2024
Q2
$69.7M Buy
364,359
+6,903
+2% +$1.32M 0.13% 162
2024
Q1
$70.8M Sell
357,456
-89,701
-20% -$17.8M 0.14% 166
2023
Q4
$76.9M Sell
447,157
-454,328
-50% -$78.2M 0.17% 139
2023
Q3
$133M Buy
901,485
+398,302
+79% +$58.9M 0.34% 74
2023
Q2
$110M Buy
503,183
+256,980
+104% +$56.2M 0.26% 91
2023
Q1
$53.9M Buy
246,203
+19,642
+9% +$4.3M 0.13% 156
2022
Q4
$47.2M Buy
226,561
+16,139
+8% +$3.36M 0.13% 173
2022
Q3
$45.9M Buy
210,422
+64,290
+44% +$14M 0.14% 161
2022
Q2
$30.9M Buy
146,132
+48,813
+50% +$10.3M 0.1% 223
2022
Q1
$23.9M Sell
97,319
-1,206
-1% -$296K 0.06% 278
2021
Q4
$25.7M Sell
98,525
-898
-0.9% -$234K 0.06% 295
2021
Q3
$26.5M Buy
99,423
+8,978
+10% +$2.39M 0.06% 294
2021
Q2
$22.3M Sell
90,445
-6,219
-6% -$1.53M 0.05% 337
2021
Q1
$18.8M Buy
96,664
+8,898
+10% +$1.73M 0.04% 358
2020
Q4
$18.7M Sell
87,766
-64,277
-42% -$13.7M 0.05% 334
2020
Q3
$26.1M Sell
152,043
-22,618
-13% -$3.88M 0.07% 231
2020
Q2
$33.5M Sell
174,661
-19,863
-10% -$3.81M 0.09% 192
2020
Q1
$28.7M Sell
194,524
-6,614
-3% -$974K 0.09% 186
2019
Q4
$31.2M Sell
201,138
-5,221
-3% -$809K 0.08% 234
2019
Q3
$27.9M Sell
206,359
-22,869
-10% -$3.09M 0.07% 253
2019
Q2
$28M Buy
229,228
+14,323
+7% +$1.75M 0.06% 294
2019
Q1
$22.3M Buy
214,905
+15,499
+8% +$1.61M 0.05% 334
2018
Q4
$22.2M Buy
199,406
+34,123
+21% +$3.79M 0.05% 306
2018
Q3
$19.1M Buy
165,283
+14,040
+9% +$1.62M 0.04% 389
2018
Q2
$15.7M Buy
151,243
+126,002
+499% +$13.1M 0.03% 414
2018
Q1
$2.49M Sell
25,241
-456
-2% -$44.9K ﹤0.01% 641
2017
Q4
$2.18M Buy
25,697
+462
+2% +$39.1K ﹤0.01% 662
2017
Q3
$1.94M Buy
+25,235
New +$1.94M ﹤0.01% 657